Edition:
United Kingdom

India's Cadila Healthcare Says Zydus Gets 4 ANDA Approvals From U.S FDA


Wednesday, 18 Jul 2018 

July 18 (Reuters) - Cadila Healthcare Ltd ::ZYDUS RECEIVES FOUR CONSECUTIVE ANDA APPROVALS FROM U.S FDA.SAYS PRODUCTS WILL BE MANUFACTURED AT THE GROUP'S MANUFACTURING FACILITY AT MORAIYA, AHMEDABAD.APPROVALS TO MARKET OLANZAPINE TABLETS, GLIPIZIDE EXTENDED-RELEASE TABLETS, VORICONAZOLE FOR INJECTION,FLUOCINONIDE TOPICAL SOLUTION.